The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical utility of molecular testing to select therapy in relapsed/refractory non-Hodgkin lymphoma: Mayo Clinic Center for Individualized Medicine experience.
 
Nabila Nora Bennani
No Relationships to Disclose
 
Stephen Maxted Ansell
Honoraria - Research to Practice; WebMD
Research Funding - Affimed Therapeutics (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Merck (Inst); Seagen (Inst); Trillium Therapeutics (Inst)
 
Thomas E. Witzig
Stock and Other Ownership Interests - Valeant Pharmaceuticals International
Consulting or Advisory Role - Celgene; Seagen
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Novartis (Inst); Spectrum Pharmaceuticals (Inst)
 
Andew L. Feldman
Consulting or Advisory Role - Infinity Pharmaceuticals
 
Tammy M McAllister
No Relationships to Disclose
 
Konstantinos N Lazaridis
No Relationships to Disclose
 
Jan B. Egan
No Relationships to Disclose
 
A. Keith Stewart
Stock and Other Ownership Interests - Agios; Celgene; Juno Therapeutics
Honoraria - Amgen; BMS Brazil; Celgene; Janssen; Takeda
Consulting or Advisory Role - Amgen; BMS Brazil; Celgene; Janssen; Novartis; Roche; Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Novartis
 
Grzegorz S. Nowakowski
Consulting or Advisory Role - Celgene; MorphoSys
Research Funding - Celgene (Inst)